A

Alcon

Company Research Report: Alcon



Company Overview



Name


Alcon

Mission of the Company


We aspire to lead the world in innovating life-changing vision products because when people see brilliantly, they live brilliantly.

Founded


1945

Founders


Robert Alexander and William Conner

Key People


  • David Endicott, CEO

  • Steven Smith, Director, External Communications


Headquarters


Geneva, Switzerland, and Fort Worth, Texas, USA

Number of Employees


No information is available

Revenue


No information is available

Known For


Alcon is the largest eye care device company in the world, specializing in ophthalmic surgical equipment and vision care products.

Products



Overview


Alcon offers a wide range of products in two major categories: Surgical and Vision Care.

Surgical Products



Ophthalmic Surgical Products


  • Technologies and Devices for Cataract Surgery: Includes advanced technology intraocular lenses (ATIOLs) for treating cataracts and refractive errors.

  • Vitreoretinal Surgery: Encompasses technologies for treating retinal and macula issues.

  • Refractive Surgery Products: Advanced viscoelastics and surgical packs.

  • LASIK Instruments: Devices and lasers for refractive surgery.


Vision Care Products



Contact Lenses and Lens Care Solutions


  • DAILIES TOTAL1®: Water gradient daily disposable contact lens.

  • PRECISION1®: Silicone hydrogel daily disposable contact lenses.

  • TOTAL30®: Monthly replacement, water gradient lens for extended use.

  • AIR OPTIX® COLORS: Monthly replacement color-enhancing lenses.

  • OPTI-FREE® Express: Solution for cleaning and disinfecting soft contact lenses.


Eye Care Products


  • SYSTANE® Drops: Lubricant eye drops for dry eyes.

  • Pataday® Once Daily Relief: Allergy itch relief eye drops available OTC in the US.


Key Features of Each Product


No information is available

Recent Developments



New Products Launched


  • 2021: TOTAL30® contact lenses.

  • 2022: CLAREON® family of IOLs.

  • 2022: SYSTANE® COMPLETE Preservative-Free Lubricant Eye Drops.

  • 2022: Fidelis Virtual Reality (VR) Ophthalmic Surgical Simulator.


New Features Added to Existing Products


  • OPTI-FREE® PureMoist® (2011): HydraGlyde® Moisture Matrix for better lens surface wettability.

  • AcrySof® IQ PanOptix® Trifocal IOL (2015): First trifocal IOL offering potential 20/20 vision.


New Partnerships and Acquisitions


  • 2021: Acquired US commercialization rights for Simbrinza®, expanding glaucoma presence.

  • 2022: Completed acquisition of Ivantis, adding Hydrus® Microstent to the surgical portfolio.

  • 2024: Completion of acquisition of BELKIN Vision, expanding the glaucoma portfolio with DSLT Device.


Innovation and R&D


  • 2022: Invested $702 million in research and development.

  • 2023: Opening of a new Research Clinic in Fort Worth, Texas.


Other Developments


  • Surgical Equipment Breakthroughs (2024): Unity VCS and Unity CS received U.S. FDA 510(k) clearance.

  • Executive Updates: Allen C. Ho, MD, appointed to lead the Alcon Research Institute’s Executive Committee (2024).


Conclusion


This report provides a comprehensive overview of Alcon, highlighting its product offerings, recent developments, and strategic growth through innovation and acquisitions.